LIPID-LOWERING EFFECT OF CARNITINE IN CHRONICALLY UREMIC PATIENTS TREATED WITH MAINTENANCE HEMODIALYSIS

被引：108
|
作者：
GUARNIERI, GF [1 ]
RANIERI, F [1 ]
TOIGO, G [1 ]
VASILE, A [1 ]
CIMAN, M [1 ]
RIZZOLI, V [1 ]
MORACCHIELLO, M [1 ]
CAMPANACCI, L [1 ]
机构：
[1] UNIV PADUA,INST BIOL CHEM,I-35100 PADUA,ITALY
来源：
AMERICAN JOURNAL OF CLINICAL NUTRITION | 1980年 / 33卷 / 07期
关键词：
D O I：
10.1093/ajcn/33.7.1489
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
引用
收藏
页码：1489 / 1492
页数：4
相关论文
共 50 条
  • [1] LIPID-LOWERING EFFECT OF CARNITINE IN PATIENTS WITH TYPE-IV HYPERLIPOPROTEINEMIA
    MAEBASHI, M
    KAWAMURA, N
    SATO, M
    IMAMURA, A
    YOSHINAGA, K
    LANCET, 1978, 2 (8094): : 805 - 807
  • [2] PLASMA CARNITINE AND LIPID-LOWERING DRUGS
    NESTRUCK, AC
    PANDE, SV
    DAVIGNON, J
    ATHEROSCLEROSIS, 1985, 55 (03) : 353 - 356
  • [3] Pharmacokinetics and lipid-lowering effect of fluvastatin in hypercholesterolaernic patients on maintenance haemodialysis
    Ichimaru, N
    Takahara, S
    Moriyama, T
    Kondo, M
    Nonomura, N
    Tanaka, T
    Wang, JD
    Imai, E
    Okuyama, A
    Kondo, Y
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2004, 32 (01) : 45 - 52
  • [4] Nutrition in patients treated with lipid-lowering drugs
    Bernard, MC
    Renucci, JF
    Tosello, N
    Gouvernet, J
    Vague, P
    PRESSE MEDICALE, 1997, 26 (13): : 598 - 602
  • [5] CARNITINE DEPLETION AS A PROBABLE CAUSE OF HYPERLIPIDEMIA IN UREMIC PATIENTS ON MAINTENANCE HEMODIALYSIS
    MAEBASHI, M
    IMAMURA, A
    YOSHINAGA, K
    SATO, T
    FUNYU, T
    ISHIDOYA, Y
    HIRAYAMA, N
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 139 (01): : 33 - 42
  • [6] Cost of care for patients treated with lipid-lowering drugs
    Åsa Carlsson
    Fredrik Borgström
    Jan Stålhammar
    Evo Alemao
    Don Yin
    Linus Jönsson
    PharmacoEconomics, 2004, 22 : 25 - 35
  • [7] Cost of care for patients treated with lipid-lowering drugs
    Carlsson, Å
    Borgström, F
    Stålhammar, J
    Alemao, E
    Yin, D
    Jönsson, L
    PHARMACOECONOMICS, 2004, 22 (Suppl 3) : 25 - 35
  • [8] Theoretical exposure of chronically treated patients to lipid lowering agents
    Kucera, Z
    Vlcek, J
    Hejdova, M
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (01) : 61 - 67
  • [9] Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients
    Nishizawa, Y
    Shoji, T
    Tabata, T
    Inoue, T
    Morii, H
    KIDNEY INTERNATIONAL, 1999, 56 : S134 - S136
  • [10] Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
    Graham, DJ
    Staffa, JA
    Shatin, D
    Andrade, SE
    Schech, SD
    La Grenade, L
    Gurwitz, JH
    Chan, KA
    Goodman, MJ
    Platt, R
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21): : 2585 - 2590
12345